We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+21.17%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.53B
AUM Growth
+$297M
(+24%)
Cap. Flow
+$65.9M
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
37.84%
Holding
2,861
New
260
Increased
962
Reduced
916
Closed
261
Avg Time Held Equity + Options
2.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$32M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$19M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$18.8M |
| 4 |
iShares US Medical Devices ETF
IHI
|
+$18.1M |
| 5 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$8.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$30.2M |
| 2 |
iShares MSCI USA Size Factor ETF
SIZE
|
+$10.6M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.81M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$5.72M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.98% |
| 2 | Technology | 14.37% |
| 3 | Financials | 9.13% |
| 4 | Healthcare | 5.96% |
| 5 | Consumer Discretionary | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ZGNX
2151
DELISTED
Zogenix, Inc.
ZGNX
| $3K | ﹤0.01% |
+113
| New | +$3.12K |
2020 Q2
0 quarters
|
|
2152
AllianceBernstein
AB
$3.21B
| $2K | ﹤0.01% |
106
+3
| +3% | +$70 |
2018 Q1
9 quarters
|
|
2153
Ares Commercial Real Estate
ACRE
$191M
| $2K | ﹤0.01% |
248
+129
| +108% | +$1K |
2016 Q4
14 quarters
|
|
2154
iShares MSCI ACWI ex US ETF
ACWX
$17.4B
| $2K | ﹤0.01% |
61
-392
| -87% | -$16K |
2017 Q2
12 quarters
|
|
2155
American Eagle Outfitters
AEO
$3.01B
| $2K | ﹤0.01% |
192
-2,568
| -93% | -$24.3K |
2016 Q4
14 quarters
|
|
2156
AGCO
AGCO
$7.26B
| $2K | ﹤0.01% |
39
-179
| -82% | -$9.34K |
2019 Q2
4 quarters
|
|
2157
Andersons Inc
ANDE
$2.21B
| $2K | ﹤0.01% |
+160
| New | +$2.32K |
2020 Q2
0 quarters
|
|
2158
Arrowhead Research
ARWR
$7.9B
| $2K | ﹤0.01% |
59
+35
| +146% | +$1.24K |
2020 Q1
1 quarter
|
|
2159
ATN International
ATNI
$397M
| $2K | ﹤0.01% |
40
| – | – |
2016 Q4
14 quarters
|
|
2160
Optimum Communications Inc
OPTU
$344M
| $2K | ﹤0.01% |
113
+14
| +14% | +$343 |
2020 Q1
1 quarter
|
|
2161
AllianceBernstein Global High Income Fund
AWF
$828M
| $2K | ﹤0.01% |
225
| – | – |
2016 Q4
14 quarters
|
|
2162
Bath & Body Works
BBWI
$4.06B
| $2K | ﹤0.01% |
188
-14
| -7% | -$156 |
2016 Q4
14 quarters
|
|
2163
Amplify Blockchain Technology ETF
BLOK
$978M
| $2K | ﹤0.01% |
103
| – | – |
2018 Q2
8 quarters
|
|
2164
Brookfield
BN
$81.7B
| $2K | ﹤0.01% |
159
-1
| -0.6% | -$18 |
2016 Q4
14 quarters
|
|
2165
BOK Financial
BOKF
$7.59B
| $2K | ﹤0.01% |
43
-287
| -87% | -$14.7K |
2016 Q4
14 quarters
|
|
2166
DELISTED
Carisma Therapeutics
CARM
| $2K | ﹤0.01% |
150
| – | – |
2019 Q4
2 quarters
|
|
2167
Carlyle Group
CG
$13B
| $2K | ﹤0.01% |
84
+4
| +5% | +$103 |
2020 Q1
1 quarter
|
|
2168
Calamos Convertible Opportunities and Income Fund
CHI
$894M
| $2K | ﹤0.01% |
+236
| New | +$2.25K |
2020 Q2
0 quarters
|
|
2169
Chord Energy
CHRD
$8.45B
| $2K | ﹤0.01% |
3,755
+123
| +3% | +$80 |
2016 Q4
14 quarters
|
|
|
CIO
2170
DELISTED
City Office REIT
CIO
| $2K | ﹤0.01% |
251
-834
| -77% | -$7.71K |
2017 Q1
13 quarters
|
|
2171
Cohen & Steers
CNS
$3.58B
| $2K | ﹤0.01% |
35
| – | – |
2018 Q4
6 quarters
|
|
2172
Columbia Sportswear
COLM
$3.08B
| $2K | ﹤0.01% |
34
-215
| -86% | -$15.7K |
2016 Q4
14 quarters
|
|
2173
Carpenter Technology
CRS
$18.7B
| $2K | ﹤0.01% |
91
+52
| +133% | +$1.16K |
2017 Q1
13 quarters
|
|
2174
Cytosorbents Corp
CTSO
$13M
| $2K | ﹤0.01% |
11
| – | – |
2019 Q4
2 quarters
|
|
2175
Dillards
DDS
$10.4B
| $2K | ﹤0.01% |
87
+50
| +135% | +$1.41K |
2017 Q1
13 quarters
|
|
Similar funds
Parallel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Parallel Advisors held 2,861 positions worth $1.53B, up 24% from $1.24B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Parallel Advisors deployed $65.9M of net new capital in Q2 2020, opening 260 new positions and adding to 962 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 271,902 shares worth $19.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 54% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $30.2M trimmed.
- Parallel Advisors's largest Q2 2020 buy was iShares MSCI USA Value Factor ETF: 271,902 shares worth $19.7M.
- Parallel Advisors added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $32M increase.
- Parallel Advisors's biggest Q2 2020 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $30.2M.
- Parallel Advisors fully exited iShares Core Dividend Growth ETF in Q2 2020, selling an estimated $3.38M.
- Parallel Advisors's ten largest holdings make up 38% of its $1.53B portfolio in Q2 2020.
- Parallel Advisors opened 260 new positions and closed 261 in Q2 2020.
- Parallel Advisors's portfolio value rose 24% quarter-over-quarter to $1.53B.
Based on Parallel Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.